1.
Cardiovascular highlights from non-cardiology journals
by McCabe, James M
Heart (British Cardiac Society), 2016-08, Vol.102 (16), p.1334-1334
2.
The genetic basis for cardiac remodeling
by Ahmad, Ferhaan
Annual review of genomics and human genetics, 2005, Vol.6 (1), p.185-216
3.
Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains
by Yadav, Sunil
Pflügers Archiv, 2019-01-31, Vol.471 (5), p.683-699
4.
Dilated cardiomyopathy
by Jefferies, John Lynn, MD
The Lancet (British edition), 2010, Vol.375 (9716), p.752-762
5.
Dilated cardiomyopathy
by Weintraub, Robert G, Dr
The Lancet (British edition), 2017, Vol.390 (10092), p.400-414
6.
Hypertrophic cardiomyopathy
by Maron, Barry J, MD
The Lancet (British edition), 2013, Vol.381 (9862), p.242-255
7.
Inherited cardiomyopathies in veterinary medicine
by Stern, Joshua A
Pflügers Archiv, 2018-10-03, Vol.471 (5), p.745-753
8.
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
by Eschenhagen, Thomas
Pflügers Archiv, 2018-10-15, Vol.471 (5), p.755-768
9.
Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients
by Hu, Da-Jun
International Journal of Cardiovascular Imaging, 2016-08-26, Vol.32 (12), p.1725-1733
10.
Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
by Ismail, Tevfik F
Heart (British Cardiac Society), 2014-12, Vol.100 (23), p.1851-1858
11.
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment
by Siddiqi, Omar K
Trends in cardiovascular medicine, 2018-01, Vol.28 (1), p.10-21
12.
Unraveling obscurins in heart disease
by Grogan, Alyssa
Pflügers Archiv, 2018-08-11, Vol.471 (5), p.735-743
13.
Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
by Kuusisto, Johanna
Heart (British Cardiac Society), 2012-07, Vol.98 (13), p.1007-1013
14.
Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
by Spudich, James A
Pflügers Archiv, 2019-02-15, Vol.471 (5), p.701-717
15.
Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
by Lopes, Luis R
Heart (British Cardiac Society), 2015-02, Vol.101 (4), p.294-301
16.
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated ca...
by Rossi, Andrea
Heart (British Cardiac Society), 2011-10, Vol.97 (20), p.1675-1680
17.
A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy
by Ingles, Jodie
Heart (British Cardiac Society), 2012-04, Vol.98 (8), p.625-630
18.
Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis
by Briasoulis, Alexandros
Heart (British Cardiac Society), 2015-09, Vol.101 (17), p.1406-1411
19.
Pathogenesis and diagnosis of myocarditis
by Elamm, Chantal
Heart, 2012-06, Vol.98 (11), p.835-8
20.
Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic Cardiomyopathy
by Klarich, Kyle W., MD
The American journal of cardiology, 2013, Vol.111 (12), p.1784-1791
